Jones Day makes ‘substantive legal contributions’ to clients’ efforts in the life sciences field, managing several high value mergers in the sector, while also providing support and representation in relation to clients’ IP portfolios and issues under federal drug pricing statutes. The firm is also sought after for advice in relation to digital health and telemedicine, with practice co-head Alexis Gilroy, who splits time between Washington DC and Atlanta, advising on the structuring of telehealth services and assisting with transactions in the sector. Leading the team alongside her is Chicago-based Heather O’Shea, whose practice spans regulatory compliance issues and litigation arising out of healthcare fraud allegations under the FCA and Anti-Kickback Statute.
Legal 500 redaktioneller Kommentar
Auszeichnungen
Mandantenzufriedenheit
Referenzen
Unabhängig vom Legal 500-Forschungsteam zusammengestellt.
- 'The team works seamlessly together to update and inform each other to ensure alignment on global strategy. The team is incredibly responsive, creative in approach, and expert in substantive legal contributions.'
Kernmandanten
- Celgene
- Labcorp
- Bristol-Myers Squibb
- DePuy Synthes
- Sumitomo Pharma Co. Ltd.
- Astellas Pharma Inc.
Anwält*innen
Praxisleitung
Alexis Gilroy; Heather O'Shea
Weitere Kernanwält*innen
Colleen Heisey